02.11.2022 • News

Curia Begins Work on New Mexico Expansion

US CDMO Curia has begun construction on an expansion of its campus in Albuquerque, New Mexico. The facility designed by Burns & McDonnell will be built by BE&K Building Group.

Improvements will include a new advanced isolated high-speed fill-finish vial line, which includes biosafety level 2 (BSL-2) containment as well as two lyophilizers for the high-speed fill-finish and an isolated flexible filling line for vials, syringes and cartridges to support smaller-batch advanced therapies.

The flexible filling line and high-speed fill-finish vial lines are planned to be operational in 2025.

Backing the expansion project designed to support the domestic production of injectable medicines are US preparedness authorities such as Biomedical Advanced Research and Development Authority (BARDA) and the Administration for Strategic Preparedness and Response (ASPR), both part of the Department of Health and Human Services (HHS), as well as the Department of Defense and the US Army Contracting Command’s Joint Covid Response Division.

The US state of New Mexico is also supporting the expansion through assistance from the Local Economic Development Act (LEDA) job creation fund, and Curia can expect state assistance for employee job training. The CDMO said the expansion will allow it to make a greater contribution to the production of vaccines and treatments.

Author: Dede Williams, Freelance Journalist
 

Event included Gov. Michelle Lujan Grisham, Economic Development Cabinet...
Event included Gov. Michelle Lujan Grisham, Economic Development Cabinet Secretary, Alicia J. Keyes and Albuquerque Mayor Tim Keller. © Curia

Company

Logo:

Curia


Albany, NY
US

Company contact







Interview

Leading Transformation
The Path to Sustainable Growth

Leading Transformation

As Executive Vice President of International Chemicals since early 2024, Antje Gerber has been steering Sasol through a pivotal reset—focused on resilience, innovation, and bold sustainability goals.

Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.